Skip to content
AwardedIRLServices€75,000

AG3147C UL RFT for the Provision of a Preclinical Bioavailability Study for a Drug Nanoparticle Formulation

Published
Published 17 June 2025
Deadline
Closed 28 March 2025

Overview

Our objective is to conduct a study in animals that compares the pharmacokinetics of 2 oral formulations of the same drug or active pharmaceutical ingredient (API). One of the oral formulations is developed inhouse (Nanocomp), and the other is a formulation currently available in the market (Commercial). The question we intend to answer using standard pharmacokinetic analysis is: would the novel oral formulation be superior to the available formulation?

Key details

Country
IRL
Status
Awarded
Category
Services
Estimated value
€75,000
Procedure
Open
Published
17 June 2025
Questions by
21 March 2025
Deadline
Closed
Classification (CPV)
Analysis servicesAgricultural servicesMedical analysis servicesVeterinary services

Award outcome

Awarded value
€69,800
Award date
17 June 2025

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    17 June 2025

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: AG3147C UL RFT for the Provision of a Preclinical Bioavailability Study for a Drug Nanoparticle Formulation — Skim